NYC Emerging Technologies Summit --- Opportunities in Neuroscience

NYC Emerging Technologies Summit

-- Opportunities in Neuroscience

Please join NYC’s leading research institutions for an afternoon of presentations and networking on exciting commercialization opportunities within the thriving neuroscience sector. Meet innovators, entrepreneurs, and investors, who are driving the most promising, investor-ready innovation in the field of neuroscience research.

Nine leading research institutions will participate. Event sponsors include the New York City Investment Fund, Alexandria Real Estate Equities, and Merck.

Program Benefits include:

• One-stop shopping for investor-ready opportunities in the field of neuroscience, backed by the world-class research of universities and medical centers located in New York City
• Access to impactful ideas with strong market potential from innovators at the forefront of science, engineering, and medicine
• Keynote covering important new developments and trends in the commercialization efforts of neuroscience areas
• Networking with key deal makers in the research and investment communities

Agenda

1:00-1:15         Welcoming Remarks   (CUNY)

1:15‐1:35         Keynote Speech      

Ellis Rubinstein, President, The New York Academy of Sciences

1:35     State University of New York (including SUNY Stony Brook and SUNY downstate /upstate Medical College)

Dale Deutsch, PhD:  Endocannabinoid Transporters as Therapeutic Targets

1:50     Rockefeller University

Thomas Sakmar, PhD:  Halting the Amyloid March --How a novel Ca2+-binding protein, NUCB1, prevents the formation of amyloid fibrils

Mary Jeanne Kreek, MD:  Modulation of the mu opioid receptor: Implications for stress responsivity, pain, and addictive diseases.

2:05     New York University

Eric Stone, PhD: Rapid and potent new class of antidepressant and anti-anxiety drugs

Einar Sigurdsson, PhD: Tau immunotherapy for Alzheimer's Disease and related Tauopathies

2:20‐2:40         Networking / Coffee Break / Poster

2:40     Mount Sinai School of Medicine

2:55     Memorial Sloan Kettering Cancer Center

Gabriela Chiosis, PhD:  Treatment of neurodegenerative diseases through inhibition of Hsp90.

3:10     Cornell University

Rajiv R. Ratan MD,PhD:  Small Molecule HIF activators

3:25‐3:45         Networking / Coffee Break / Poster

3:45     Columbia University

Ottavio Arancio, MD/ PhD: Histone Acetyltransferase (HAT) Activators for the Treatment of Neurodegeneration

Barbara Hanna, PhD: Brain Machine Interface Systems for High-Throughput Image Search

4:00     City University of New York

Marom Bikson, PhD: High-Definition Transcranial Electrical Stimulation (HD-tES): Non invasive, low-intensity, electrical Neurostimulation

4:15     Albert Einstein College of Medicine

Solomon L. Moshe, M.D.: Infantile Spasm Syndrome: Identifying Novel Treatments for This Devastating Condition

4:30-6:00        Networking Cocktails & Poster Session

Opportunities will include neuroscience-related inventions addressing different types of unmet commercial needs and patient populations, in fields that include:

                        •  Therapeutics

                       •  Software/Device

                       •  TBD

                       •  TBD

“Opportunities in Neuroscience” is the third in a series of conferences hosted by New York City’s leading academic research institutions to highlight the world-class research of NYC universities and medical centers. A March 2010 conference, focusing on medical device sector and hosted by Columbia University, and an October 2010 second conference “Opportunities in Oncology”, hosted by Memorial Sloan-Kettering Cancer Center, brought together key deal makers and researchers in the corresponding fields.

“Opportunities in Neuroscience” is sponsored by Alexandria Real Estate and Merck, with other potential sponsors to be confirmed later.

Please contact Elaine Lu at Elaine.lu@mail.cuny.edu or Wei Chen at Wei.Chen@mail.cuny.edu if you have any questions.

-------------------------------------------------------------------------------------------------

LES Spring Meeting: Spotlight On Life Sciences

May 4-6 - New York, NY

Attend this meeting and network with top executives from Baxter, Becton Dickinson, Columbia, MIT, Merck, Pfizer, Purdue Pharma & more at the year's premier event for IP, licensing, technology transfer and business development professionals. Hear USPTO Director David Kappos address the state of IP in life sciences. For more info and to register, visit www.les2011spring.org